Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin

Journal of Molecular Endocrinology

Volumn 38, Issue 1-2, 2007, Pages 181-192

  Kidd, Mark ^a   Eick, Geeta N ^a   Modlin, Irvin M ^a   Pfragner, Roswitha ^b   Champaneria, Manish C ^a   Murren, John ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' DIDEOXYADENOSINE; ALPHA 1C ADRENERGIC RECEPTOR; ANGIOPEPTIN; BETA 1 ADRENERGIC RECEPTOR; CHROMOGRANIN A; CYCLIC AMP; DOPAMINE 2 RECEPTOR; GEFITINIB; GUANYLIN; ISOPRENALINE; MUSCARINIC M4 RECEPTOR; NICOTINIC RECEPTOR; RAPAMYCIN; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SUBSTANCE P; TRANSCRIPTOME; TRYPTOPHAN HYDROXYLASE; VESICULAR MONOAMINE TRANSPORTER 1;

ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOID; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CELL VACUOLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; ENTEROCHROMAFFIN CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE CANCER; TRANSMISSION ELECTRON MICROSCOPY;

CELL LINE, TUMOR; ENTEROCHROMAFFIN CELLS; HUMANS; NEUROSECRETORY SYSTEMS; PEPTIDES, CYCLIC; SIROLIMUS; SOMATOSTATIN;

EID: 33847687195     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.02037     Document Type: Article

References (66)

1. Ahlman H, Wigander A, Molne J, Nilsson O, Karlsson JE, Theodorsson E & Dahlstrom A 1989 Presence of nerve growth factor-like immunoreactivity in carcinoid tumour cells and induction of a neuronal phenotype in long-term culture. International Journal of Cancer 43 949-955.
2. Arnold R, Trautmann ME, Creutzfeldt W, Benning R, Benning M, Neuhaus C, Jurgensen R, Stein K, Schafer H, Bruns C et al. 1996 Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. GUT 38 430-438.
3. Barber DL, Buchan AM, Walsh JH & Sell AH 1986a Regulation of neurotensin release from canine enteric primary cell cultures. American Journal of Physiology 250 G385-G390.
4. Barber DL, Buchan AM, Walsh JH & Soil AH 1986b Isolated canine ileal mucosal cells in short-term culture: a model for study of neurotensin release. American Journal of Physiology 250 G374-G384.
5. Begueret H, Vergier B, Begueret J, Vernejoux JM, Jougon J, Trouette R, Taytard A, Velly JF, Merlio JP & de Mascarel A 2002 Detection of Circulating cells expressing chromogranin A gene transcripts in patients with lung neuroendocrine carcinoma. European Journal of Cancer 38 2325.
6. Bissonnette RT, Gibney RG, Berry BR & Buckley AR 1990 Fatal carcinoid crisis after percutaneous fine-needle biopsy of hepatic metastasis: case report and literature review. Radiology 174 751-752.
7. Boushey RP & Dackiw AP 2002 Carcinoid tumors. Current Treatment Options in Oncology 3 319-326.
8. Buchan AM, Barber DL, Gregor M & Soll AH 1987 Morphologic and physiologic studies of canine ileal enteroglucagon-containing cells in short-term culture. Gastroenterology 93 791-800.
9. Buchli R, Ndoye A, Arredondo J, Webber RJ & Grando SA 2001 Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes. Molecular and Cellular Biochemistry 228 57.
10. Chernogubova E, Hutchinson DS, Nedergaard J & Bengtsson T 2005 α1- and β1-Adrenoceptor signaling fully compensates for β3-adrenoceptor deficiency in brown adipocyte norepinephrine-stimulated glucose uptake. Endocrinology 146 2271-2284.
11. Danila DC, Haidar JN, Zhang X, Katznelson L, Culler MD & Klibanski A 2001 Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors. Journal of Clinical Endocrinology and Metabolism 86 2976-2981.
12. Debons-Guillemin MC, Launay JM, Roseto A & Peries J 1982 Serotonin and histamine production by human carcinoid cells in culture. Cancer Research 42 1513-1516.
13. Evers BM, Townsend CM Jr, Upp JR, Allen E, Hurlbut SC, Kim SW, Rajaraman S, Singh P, Reubi JC & Thompson JC 1991 Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology 101 303-311.
14. Fujimiya M, Okumiya K & Kuwahara A 1997 Immunoelectron microscopic study of the luminal release of serotonin from rat enterochromaffin cells induced by high intraluminal pressure. Histochemistry and Cell Biology 108 105-113.
15. Gershon MD 2003 Plasticity in serotonin control mechanisms in the gut. Current Opinion in Pharmacology 3 600-607.
16. Goke R, Gregel C, Goke A, Arnold R, Schmidt H & Lankat-Buttgereit B 2004 Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells. Annals of the New York Academy of Sciences 1014 220-221.
17. Gustafsson BI, Thommesen L, Stunes AK, Tommeras K, Westbroek I, Waldum HL, Slordahl K, Tamburstuen MV, Reseland JE & Syversen U 2006 Serotonin and fluoxetine modulate bone cell function in vitro. Journal of Cellular Biochemistry 98 139-151.
18. Harmar AJ, Armstrong A, Pascall JC, Chapman K, Rosie R, Curtis A, Going J, Edwards CR & Fink G 1986 cDNA sequence of human beta-preprotachykinin, the common precursor to substance P and neurokinin A. FEBS Letters 208 67-72.
19. Hayflick L 1973 Subculturing human diploid fibroblast cultures. In Tissue Culture Methods and Applications, pp 220-223. Eds PF Kruse & MK Patterson. New York: Academic Press.
20. Hill AA, Hunter CP, Tsung BT, Tucker-Kellogg G & Brown EL 2000 Genomic analysis of gene expression in C. elegans. Science 290 809-812.
21. Hofsli E, Thommesen L, Yadetie F, Langaas M, Kusnierczyk W, Falkmer U, Sandvik AR & Laegreid A 2005 Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells. British Journal of Cancer 92 1506-1516.
22. Hopfner M, Sutter AP, Gerst B, Zeitz M & Scherubl H 2003 A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839). British Journal of Cancer 89 1766-1775.
23. Hopfner M, Sutter AP, Huether A, Ahnert-Hilger G & Scherubl H 2004 A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-gamma and meta-iodobenzylguanidine. BMC Cancer 4 23.
24. Huynh TT, Pacak K, Brouwers FM, Abu-Asab MS, Worrell RA, Walther MM, Elkahloun AG, Goldstein DS, Cleary S & Eisenhofer G 2005 Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. European Journal of Endocrinology 153 551-563.
25. Imam H, Eriksson B, Lukinius A, Janson ET, Lindgren PG, Wilander E & Oberg K 1997 Induction of apoptosis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs. Acta Oncologica 36 607-614.
26. Jacinto E & Hall MN 2003 Tor signalling in bugs, brain and brawn. Nature Reviews. Molecular Cell Biology 4 117-126.
27. Jung Y, Oh SH, Zheng D, Shupe TD, Witek RP & Petersen BE 2006 A potential role of somatostatin and its receptor SSTR4 in the migration of hepatic oval cells. Laboratory Investigation 86 477-489.
28. Kahn S, Yamamoto F, Almoguera C, Winter E, Forrester K, Jordano J & Perucho M 1987 The c-K-ras gene and human cancer (review). Anticancer Research 7 639-652.
29. Kidd M, Eick G, Shapiro MD, Camp RL, Mane SM & Modlin IM 2005 Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors. Cancer 103 229-236.
30. Kidd M, Modlin IM, Eick GN & Champaneria MC 2006a Isolation, functional characterization and transcriptome of mastomys ileal enterochromaffin cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 291 G778-G791.
31. Kidd M, Modlin IM, Shapiro M, Camp RL, Mane SM, Usinger W & Morren JR 2006b CTGF intestinal stellate cells and carcinoid fibrogenesis. World Journal of Gastroenterology In press.
32. Kolby L, Bernhardt P, Ahlman H, Wangberg B, Johanson V, Wigander A, Forssell-Aronsson E, Karlsson S, Ahren B, Stenman G et al. 2001 A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake. American Journal of Pathology 158 745-755.
33. Koopmans KP, Brouwers AH, De Hooge MN, Van der Horst-Schrivers AN, Kema IP, Wolffenbuttel BH, De Vries EG & Jager PL 2005 Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid. Journal of Nuclear Medicine 46 1240-1243.
34. Kuemmerle JF, Kraus H & Kellum JM 1987 Serotonin release is mediated by muscarinic receptors on duodenal mucosal cells. Journal of Surgical Research 43 139-142.
35. Lee SH, Paeng JP, Jung HH, Lee SH, Lee HM, Kwon SY, Lim KJ & Jung KY 2004 Expression of guanylin and uroguanylin mRNA in human nasal mucosa and nasal polyps. Arta Otolaryngology 124 179-185.
36. Lindstrom E, Bjorkqvist M, Boketoft A, Chen D, Zhao CM, Kimura K & Hakanson R 1997 Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells. Regular Peptides 71 73-86.
37. Maurer P, Rorive S, de Kerchove d'Exaerde A, Schiffmann SN, Salmon I & de Launoit Y 2004 The Ets transcription factor Fev is specifically expressed in the human central serotonergic neurons. Neuroscience Letters 357 215.
38. Modlin IM, Lawton GP, Tang LH, Geibel J, Abraham R & Darr U 1994 The mastomys gastric carcinoid: aspects of enterochromaffin-like cell function. Digestion 55 (Suppl 3) 31-37.
39. Modlin IM, Lye KD & Kidd M 2003 A 5-decade analysis of 13 715 carcinoid tumors. Cancer 97 934-959.
40. Modlin IM, Shapiro MD & Kidd M 2004 Carcinoid tumors and fibrosis: an association with no explanation. American Journal of Gastroenterology 99 2466-2478.
41. Modlin IM, Kidd M, Latich I, Zikusoka MN & Shapiro MD 2005 Current status of gastrointestinal carcinoids. Gastroenterology 128 1717-1751.
42. Modlin IM, Kidd M, Pfragner R, Eick GN & Champaneria MC 2006 The functional characterization of normal and neoplastic human enterochromaffin cells. Journal of Clinical Endocrinology and Metabolism 91 2340-2348.
43. Nilsson O, Wangberg B, Theodorsson E, Skottner A & Ahlman H 1992 Presence of IGF-I in human midgut carcinoid tumours - an autocrine regulator of carcinoid tumour growth? International Journal of Cancer 51 195-203.
44. Park, JG, Oie HK, Sugarbaker PH, Henslee JG, Chen TR, Johnson BE & Gazdar A 1987 Characteristics of cell lines established from human colorectal carcinoma. Cancer Research 47 6710-6718.
45. Patel YC, Greenwood MT, Panetta R, Demchyshyn L, Niznik H & Srikant CB 1995 The somatostatin receptor family. Life Science 57 1249-1265.
46. Pfragner R, Wirsnsberger G, Niederle B, Behmel A, RInner I, Mandl A, Wawrina F, Luo J, Adamiker D, Hoger H et al. 1996 Establishment of a continuous cell line from a human carcinoid of the small intestine (KRJ-I): characterization and effects of 5-azacytidine on proliferation. International Journal of Oncology 8 513-520.
47. Plockinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW, Goede A, Caplin M, Wiedenmann B, Oberg K et al. 2005 Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. Neuroendocrinology 80 394-424.
48. Qin B, Ariyama H, Baba E, Tanaka R, Kusaba H, Harada M & Nakano S 2006 Activated Src and Ras incluce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells. Cancer Chemotherapy and Pharmacology In press.
49. Quinn LA, Moore GE, Morgan RT & Woods LK 1979 Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Research 39 4914-4924.
50. Rao RD, Mladek AC, Lamont JD, Goble JM, Erlichman C, James CD & Sarkaria JN 2005 Disruption of parallel and converging signaling pathways contributes to the synergistic antitumor effects of simultaneous mTOR and EGFR inhibition in GBM cells. Neoplasia 7 921-929.
51. Rohaizak M & Farndon JR 2002 Use of octreotide and lanreotide in the treatment of symptomatic non-resectable carcinoid tumours. ANZ Journal of Surgery 72 635-638.
52. Rowinsky EK 2004 Targeting the molecular target of rapamycin (mTOR). Current Opinion in Oncology 16 564-575.
53. Sandor A, Kidd M, Lawton GP, Miu K, Tang LH & Modlin IM 1996 Neurohormonal modulation of rat enterochromaffin-like cell histamine secretion. Gastroenterology 110 1084-1092.
54. Schally AV 1988 Oncological applications of somatostatin analogues. Cancer Research 48 6977-6985.
55. Sippel RS & Chen H 2002 Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation. Surgery 132 1035-1039 (Discussion 1039).
56. Sippel RS, Carpenter JE, Kunnimalaiyaan M, Lagerholm S & Chen H 2003 Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 285 G245-G254.
57. Tamir H, Liu KP, Hsiung SC, Adlersberg M, Nunez EA & Gershon MD 1990 Multiple signal transduction mechanisms leading to the secretion of 5-hydroxytryptamine by MTC cells, a neurectodermally derived cell line. Journal of Neuroscience 10 3743-3753.
58. Tinajero JC, Fabbri A, Ciocca DR & Dufau ML 1993 Serotonin secretion from rat Leydig cells. Endocrinology 133 3026-3029.
59. Tran VS, Marion-Audibert AM, Karatekin E, Huet S, Cribier S, Guillaumie K, Chapuis C, Desnos C, Darchen F & Henry JP 2004 Serotonin secretion by human carcinoid BON cells. Annals of the New York Academy of Sciences 1014 179-188.
60. Van Gompel JJ & Chen H 2004 Insulin-like growth factor 1 signaling in human gastrointestinal carcinoid tumor cells. Surgery 136 1297-1302.
61. Van Gompel JJ, Kunnimalaiyaan M, Holen K & Chen H 2005 ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. Molecular Cancer Therapeutics 4 910-917.
62. Wallukat G 2002 The beta-adrenergic receptors. Herz 27 683-690.
63. Westberg G, Ahlman H, Nilsson O, Illerskog A & Wangberg B 1997 Secretory patterns of tryptophan metabolites in midgut carcinoid tumor cells. Neurochemical Research 22 977-983.
64. von Wichert G, Jehle PM, Hoeflich A, Koschnick S, Dralle H, Wolf E, Wiedenmann B, Boehm BO, Adler G & Seufferlein T 2000 Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. Cancer Research 60 4573-4581.
65. Zatelli MC, Tagliati F, Taylor JE, Rossi R, Culler MD & degli Uberti EC 2001 Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt. Journal of Clinical Endocrinology and Metabolism 86 2161-2169.
66. Zikusoka MN, Kidd M, Eick G, Latich I & Modlin IM 2005 The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 104 2292-2309.